**** GERMAN EPISODE **** Wie werden neue Technologien, wie die künstliche Intelligenz die Pharmaindustrie beeinflussen? Welche neuen Modelle werden die Blockbuster der Vergangenheit ablösen? In dieser Folge sprechen wir mit unserem Gast Professor Jochen Maas, Geschäftsführer Forschung & Entwicklung Sanofi-Aventis, Deutschland GMBH über die Zukunft der Pharmaindustrie
Content and Editing: Louise von Stechow and Andreas Horchler
Disclaimer: Louise von Stechow, Andreas Horchler and their guests express their personal opinions, which are founded on research on the respective topics, but do not claim to give medical, investment or even life advice in the podcast.
Learn more about the future of biotech in our podcasts and keynotes. Contact us here: scientific communication: https://science-tales.com/ Podcasts: https://www.podcon.de/ Keynotes: https://www.zukunftsinstitut.de/louise-von-stechow
Image: Amanda Marie via Unsplash
06/01/23 • 39 min
Generate a badge
Get a badge for your website that links back to this episode
<a href="https://goodpods.com/podcasts/were-doomed-were-saved-the-biorevolution-podcast-360954/were-doomed-were-saved-11-51934870"> <img src="https://storage.googleapis.com/goodpods-images-bucket/badges/generic-badge-1.svg" alt="listen to we're doomed we're saved #11 on goodpods" style="width: 225px" /> </a>
Copy